Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05602025
PHASE1

A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants

Sponsor: GlaxoSmithKline

View on ClinicalTrials.gov

Summary

This study will compare the pharmacokinetics, safety, tolerability, and immunogenicity of Depemokimab administered via a SSD or autoinjector in healthy participants.

Official title: An Open-Label, Randomized, Single-Dose, Multicenter, Parallel-Group Study to Compare the Pharmacokinetics of Subcutaneous Depemokimab When Delivered With a Safety Syringe Device or an Autoinjector in Healthy Adult Participants

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2022-12-13

Completion Date

2023-10-23

Last Updated

2026-06-16

Healthy Volunteers

Yes

Conditions

Interventions

BIOLOGICAL

Depemokimab

Depemokimab was administered via SSD or autoinjector.

Locations (3)

GSK Investigational Site

Orlando, Florida, United States

GSK Investigational Site

Las Vegas, Nevada, United States

GSK Investigational Site

Austin, Texas, United States